ViewPoint is a preclinical-stage biotechnology company passionately committed to the discovery, development, and commercialization of treatments for diseases of protein misfolding, which is implicated in numerous common disorders of aging including cataracts and presbyopia.
Market
Diseases of protein misfolding
Location
San Francisco,
California,
USA
Coinvestors
Biotechnology Value Fund, Lagunita, Mission Bay Capital, Novo Holdings, The Rise Fund, University of Michigan